Good
Mostly Aligned
Patient Risk:
Low
Summary
Most claims accurately describe DEFINITY as an ultrasound contrast agent containing perflutren lipid microspheres used after activation during echocardiography for left ventricular chamber opacification and endocardial border delineation. Several broader/negative claims are not supported by the provided label excerpts.
Category Scores
Accurate Statements
Definity is a brand name for perflutren lipid microsphere.
11 DESCRIPTION: DEFINITY (perflutren lipid microsphere) injectable suspension is an ultrasound contrast agent for intravenous use.
Definity is an ultrasound contrast agent.
11 DESCRIPTION: DEFINITY (perflutren lipid microsphere) injectable suspension is an ultrasound contrast agent for intravenous use (after activation).
Definity contains perflutren in lipid microspheres.
11 DESCRIPTION: Perflutren lipid microspheres are perflutren encapsulated in an outer lipid shell.
When injected, the gas-filled microspheres enhance ultrasound signals from the bloodstream.
12.1 Mechanism of Action: activated DEFINITY enhances intrinsic backscatter of blood; physical acoustic properties provide contrast enhancement.
Definity is an imaging/diagnostic contrast agent used to support ultrasound interpretation.
12.1 Mechanism of Action and 1 INDICATIONS AND USAGE: provides contrast enhancement to delineate the left ventricular endocardial border during echocardiography.
Definity is used during echocardiography.
12.1 Mechanism of Action: aid delineation of left ventricular endocardial border during echocardiography.
Definity improves visualization of blood flow and cardiac structures during echocardiography.
12.1 Mechanism of Action: enhances intrinsic backscatter of blood providing contrast enhancement and aids delineation of the left ventricular endocardial border during echocardiography.
Definity helps clinicians see the heart’s chambers and assess blood flow with echocardiography.
1 INDICATIONS AND USAGE: opacify the left ventricular chamber and improve delineation of the left ventricular endocardial border; 12.1: provides contrast enhancement of left ventricular chamber and aid delineation.
Definity is used by clinicians during ultrasound/echocardiography procedures to improve image quality.
1 INDICATIONS AND USAGE and 12.1: used during echocardiography to opacify left ventricular chamber and improve delineation/border during echocardiography.
Definity is used to improve image quality especially when standard ultrasound images are inadequate.
1 INDICATIONS AND USAGE: indicated for patients with suboptimal echocardiograms.
Definity is an ultrasound contrast agent for intravenous use (after activation).
11 DESCRIPTION: after activation an ultrasound contrast agent for intravenous use.
Unsupported Statements
Definity is used during echocardiography.
The provided excerpt supports use during echocardiography, but not explicitly tied to 'during echocardiography' phrasing in the indication section; support is mainly from Mechanism of Action. Treated as supported overall, but mechanism-based wording does not explicitly cover procedural context.
Definity improves visualization of blood flow and cardiac structures during echocardiography.
Label excerpt specifically describes left ventricular chamber opacification and left ventricular endocardial border delineation, not general 'blood flow' or 'cardiac structures' broadly.
Definity helps clinicians see the heart’s chambers and assess blood flow with echocardiography.
Label excerpt addresses left ventricular chamber and endocardial border delineation; it does not mention 'assess blood flow' or other chambers beyond left ventricular chamber.
Contradictions
Low
AI Statement
Definity is not a medication that treats blood clots.
Label Reference
No contraindications/warnings/indications excerpt provided for thrombus treatment. Label excerpt does not support or address claims about treating blood clots.
Low
AI Statement
Definity is not a medication that lowers cholesterol.
Label Reference
No contraindications/warnings/indications excerpt provided for lipid/cholesterol-lowering. Label excerpt does not support or address claims about lowering cholesterol.
Important Omissions
Activation requirement is not stated in several claims (only one claim sequence implies activation). Label indicates DEFINITY is indicated 'after activation'.
Importance:
Moderate
Indication scope is specific to adult and pediatric patients with suboptimal echocardiograms and to opacify the left ventricular chamber and improve delineation of the left ventricular endocardial border; several claims are broader (e.g., 'cardiac structures', 'blood flow')
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
Broader descriptive claims are not supported precisely by the provided label excerpts but do not directly state an incorrect dosing/safety instruction. Negative claims about treating clots and cholesterol are not supported; however, they are unlikely to constitute direct dosing/safety risk based on the supplied information alone.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Several claims broaden the intended effect beyond what the provided label excerpt states (left ventricular chamber opacification and left ventricular endocardial border delineation) and include unsupported negative statements about clot treatment and cholesterol-lowering.
Suggested Improvement
Constrain descriptions to the provided indication/mechanism wording (opacify the left ventricular chamber and improve delineation of the left ventricular endocardial border in patients with suboptimal echocardiograms) and avoid unsubstantiated claims about treating clots or lowering cholesterol unless supported in the provided label sections.